Partitioning ectoderm precisely into neurogenic and non-neurogenic regions is an essential step for neurogenesis of almost all bilaterian embryos. Although it is widely accepted that the antagonism between BMP and its inhibitors primarily sets up the border between these two types of ectoderm, it is unclear how such extracellular, diffusible molecules create a sharp and precise border at the single-cell level. Here, we show that Fez, a zinc finger protein, functions as an intracellular factor attenuating BMP signaling specifically within the neurogenic region at the anterior end of sea urchin embryos, termed the animal plate. When Fez function is blocked, the size of this neurogenic ectoderm becomes smaller than normal. However, this reduction is rescued in Fez morphants simply by blocking BMP2/4 translation, indicating that Fez maintains the size of the animal plate by attenuating BMP2/4 function. Consistent with this, the gradient of BMP activity along the aboral side of the animal plate, as measured by pSmad1/5/8 levels, drops significantly in cells expressing Fez and this steep decline requires Fez function.
Introduction
Nervous system development in bilaterians is composed of a number of developmental processes, such as partitioning the ectoderm into neuroectoderm and non-neuroectoderm, patterning the neuroectoderm, and differentiation of neural cells including neural network formation. Among these, partitioning of ectoderm is one of the earliest and the most critical events because all of the following processes of neurogenesis depend on it. In vertebrates, the prospective neuroectoderm is formed at the future dorsal side by the function of the Spemann organizer, which can induce an ectopic neuroectoderm when grafted to the ventral region of the embryo (Spemann and Mangold, 1924) . From a number of previous studies analyzing the inductive function of the organizer, we now know the molecular entities mediating this induction are diffusible extracellular molecules such as Chordin, Noggin, and Follistatin (De Robertis and Kuroda, 2004) . These molecules antagonize the function of BMP, a member of TGF-ß superfamily, on the dorsal side protecting this region from BMP-mediated induction of non-neuroectoderm (Khokha et al., 2005) . When one or two of them are knocked down, The neurogenic ectoderm of the embryo of the sea urchin, a basal deuterostome, consists of two major parts. One is the ectoderm at the animal pole that is highly related to the vertebrate anterior neuroectoderm, judged from the temporal and spatial expression patterns of genes encoding regulatory factors, and from the fact that canonical Wnt signaling is involved in positioning the region anteriorly during cell-fate specification at early embryogenesis (Wikramanayake et al., 1998; Kiecker and Niehrs, 2001; Wei et al., 2009 ). The second forms within the ciliary band located at the border between oral and aboral signaling territories (Duboc et al., 2004; Yaguchi et al., 2006; Wei et al., 2009; Lapraz et al., 2009; Yaguchi et al., 2010a; Saudemont et al., 2010) . The anterior neurogenic region, called the animal plate is the focus of the present study. FoxQ2 is among several genes that are the earliest to be specifically expressed in neurogenic ectoderm. FoxQ2 transcripts appear in the entire animal half at 32-cell stage and are progressively restricted to the animal pole region in pre-hatching blastulae (Tu et al., 2006; Yaguchi et al., 2008) . This process restricts at least several genes required for animal plate development and depends on the Wnt/ß-catenin pathway, which functions in the vegetal hemisphere (Logan et al., 1999; Yaguchi et al., 2008) . After the restriction of FoxQ2-positive region is completed at the blastula stage, the prospective neuroectoderm starts to express additional genes specific for nervous system development (Wei et al., factors during early development, are transcribed on the oral side and then, BMP2/4 diffuses to the aboral ectoderm. Both Nodal and BMP2/4 induce non-neurogenic ectoderm fates (Angerer et al., 2000; Duboc et al., 2004; Bradham et al., 2009; Lapraz et al., 2009; Saudemont et al., 2010) . The prospective animal plate, as well as ciliary band, neuroectoderm must have robust mechanisms that antagonize these signals and maintain their precise sizes during these stages. Here, we report that, in the animal plate, FoxQ2 induces production of an intracellular transcription factor, Fez (forebrain embryonic zinc finger), at blastula stage that specifically attenuates BMP signaling, thereby maintaining and stabilizing the border of the anterior neuroectoderm in the sea urchin embryo.
Materials and Methods

Animals and embryo culture
Adult sea urchins, Strongylocentrotus purpuratus, were obtained from The was added at hatching blastula stage to a final concentration of 20 µM.
Microarray
Sample preparation, microarray, and data processing were described previously (Wei et al., 2006) . The double-strand cDNAs synthesized from control embryos and SpFoxQ2 morphants were labeled, hybridized, and scanned by Roche Nimblegen microarray services. The microarray was prepared based on S. purpuratus genome sequence information (Wei et al., 2006; Sea Urchin Genome Sequencing Consortium, 2006) and hybridized with amplified cDNAs isolated from S. purpuratus mesenchyme blastulae either containing or lacking SpFoxQ2-MO1 previously described (Yaguchi et al., 2008 ; see below). FoxQ2-dependent genes identified in the microarray were confirmed by in situ hybridization in H. pulcherrimus embryos, as described below and by quantitative polymerase chain reaction (QPCR) as previously described (Yaguchi et al., 2010b) .
Microinjection of morpholino antisense oligonucleotides (MO) and synthetic mRNAs
Microinjection was performed as described previously (Yaguchi et al., 2010b) .
We used the following morpholinos (Gene Tools, Philomath, OR, USA) at the indicated concentrations in 24% glycerol in injection needles: SpFoxQ2-MO1 (800 µM; Yaguchi et al., 2008), FoxQ2-MO (200 µM; Yaguchi et al., 2010b) , Fez-MO1 (1.9 mM), Fez-MO2
(1.6 mM), BMP2/4-MO (400 µM), Smad1/5/8-MO (1.0 mM). All morpholinos were designed against H. pulcherrimus genes except for the SpFoxQ2-MO1 that blocks S. purpuratus FoxQ2 translation. The morphant phenotypes were the same as those previously published (Duboc et al., 2004; Yaguchi et al., 2008) . The morpholino sequences were the following: Fez-MO1: 5'-GAATGCTTTTTTCATGCACTAAAGA-3', Fez-MO2: 5'-GCGTTCAAATCTACTTAAGGAGTGT-3', BMP2/4-MO: 5'-GACCCCAATGTGAGGTGGTAACCAT-3', and Smad1/5/8-MO: 5'-GCCATCGACATAGTGGAGCAAGCTT-3'. mRNAs were synthesized from linearized plasmids using the mMessage mMachine kit (Life Technologies, Carlsbad, CA, USA), and injected at the indicated concentrations in 24% glycerol in injection needles: ∆ -cadherin (0.3-0.6 µg/µl; Logan et al., 1999) , Fez-mRNA (2.0 µg/µl), BMP2/4-mRNA (2.5 µg/µl), actSmad2/3-mRNA (2.5 µg/µl; Yaguchi et al., 2007) .
Whole-mount in situ hybridization and immunohistochemistry
Whole-mount in situ hybridization was performed as described previously (Minokawa et al., 2004; Yaguchi et al., 2010b) . The foxQ2-positive cell number for the experiment in Figure 5 was determined by counting DAPI signals in the foxQ2 region through serial optical sections. Immunohistochemistry for detecting serotonin, synaptotagminB (synB), and Nk2.1 was performed as described previously (Yaguchi et al., 2006) . To detect FoxQ2 and pSmad1/5/8 immunochemically, embryos were fixed with 4% paraformaldehyde-FSW for 10 min. After washing with phosphate-buffered saline containing 0.5% Tween-20 (PBS-T) five times, the embryos were blocked with 1% skim milk (Difco; BD, Franklin Lakes, NJ, USA) in PBS-T and incubated with primary antibodies diluted as follows with Can Get Signal immunostain solution B (TOYOBO, Tokyo, Japan): mouse anti-FoxQ2 IgG 1:100, rabbit anti-pSmad1/5/8 (Cell Signaling Technology #9511; Danvers, MA, USA) 1:1000.
The primary antibodies were detected with secondary antibodies conjugated with Alexa-568 for FoxQ2 and Alexa-488 for pSmad1/5/8 (Life Technologies). The specimens were observed with a Zeiss Axio Imager.Z1 equipped with Apotome system, and optical sections were stacked and analyzed with ImageJ and Adobe Photoshop.
Panels and drawings for figures were made with CANVAS software.
Anti-FoxQ2 antibody preparation
cDNA encoding full-length FoxQ2 was cloned into the pET vector (Novagen, Darmstadt, Germany) and histidine-tagged FoxQ2 was induced in bacteria with IPTG.
The bacteria were lysed with 6 M Urea, and the fusion protein was purified by Ni-column chromatography and used to immunize three mice. Antisera were screened by whole-mount immunohistochemistry, and IgG was purified with Melon gel (Thermo Fisher Scientific, Waltham, MA, USA).
Results
Fez expression depends strongly on FoxQ2 during blastula stages.
FoxQ2 is expressed very early in the prospective animal plate of sea urchin embryos and is required for the development of neurons in this region of the embryonic nervous system. We searched for regulatory genes downstream of FoxQ2 required for formation of the animal plate using a microarray approach to identify genes strongly down regulated in FoxQ2 morphants at the blastula stage of Strongylocentrotus purpuratus. Previous studies have shown this approach to be successful in identifying genes whose expression depends on upstream regulatory proteins (Wei et al., 2009; Yaguchi et al., 2010b) . One candidate FoxQ2-dependent regulatory gene encoded an apparent ortholog of Fez, forebrain embryonic zinc finger, (SPU_027491; Sea Urchin Genome Sequencing Consortium, 2006) . We recovered this gene from the genome of the Japanese sea urchin, Hemicentrotus pulcherrimus, and found that it contains sequences encoding an engrailed homology repressor motif 1 (EH1) at the N-terminal region and six zinc finger domains at C-terminus (accession number; AB610478), as previously reported for vertebrate Fez or Fez-like proteins (e.g. mice; AK014242 and AB042399, Hirata et al., 2006b) . Because of its containing EH1, Fez is thought to function as a transcriptional repressor (Hirata et al., 2006a) . After confirming the microarray result that, during blastula stages, H. pulcherrimus FoxQ2 morphants have significantly decreased fez mRNA levels by in situ hybridization and QPCR ( Fig. 1M-O) , we focused on the function of Fez in neurogenesis.
Expression of fez during development
To examine the gene expression pattern of fez, we performed in situ hybridization at stages from egg to pluteus larva. No signals were detected before hatching ( Fig. 1A) , consistent with the temporal profiling data conducted by Wei et al., (2006) using microarrays. After hatching, fez transcripts accumulate throughout the entire animal plate (Fig, 1B) until early gastrula stage (Fig. 1C ). After the embryo reaches mid-gastrula stage, the uniform expression fades and is progressively replaced by stronger signals in a few individual cells within the animal plate ( Fig. 1D -F, asterisks).
To compare fez and foxQ2 expression patterns in detail, we employed fluorescent in situ hybridization. fez is expressed at low levels in the animal plate at hatching blastula stage ( Fig. 1G ) but much stronger at mesenchyme blastula stage and in a pattern that is almost identical to that of foxQ2 ( Fig. 1H ). As shown with chromogenic detection (Fig. 1D ), fez transcripts accumulate in individual cells at gastrula stage, whereas foxQ2 expression remains uniform throughout the animal plate ( Fig. 1I, J) . The expression domain of foxQ2 is restricted to the oral side of the animal plate at later stages (Yaguchi et al., 2008) whereas 3-5 individual fez-positive cells are located on the opposite (aboral) side at that time ( Fig. 1K ; insets in Fig. 1I '', J'', K''). To examine which cell type(s) express fez mRNA, we compared the distributions of tryptophan 5-hydroxylase (tph) and fez mRNAs by double fluorescent in situ hybridization. Because TPH is the rate-limiting enzyme in serotonin synthesis, it is a specific marker for serotonergic neurons in sea urchin embryos (Yaguchi and Katow, 2003) . At the prism stage, fez is clearly expressed in the serotonergic neurons although each mRNA localizes to a slightly different position in the same cell ( Fig. 1L ). Because the expressions of fez and foxQ2 do not overlap at later stages fez expression does not depend on FoxQ2 at that time ( Fig. 1O ). In summary, fez is expressed throughout the animal plate between hatching blastula and gastrula stages, and in serotonergic neural precursors and neurons after gastrulation.
Fez controls the size of the animal plate.
To examine Fez function in sea urchin development and neurogenesis, we performed knockdown and mis-expression experiments by injecting morpholino anti-sense oligonucleotides (MO) and mRNA encoding full-length Fez protein, respectively. In Fez morphants, the timing of cleavage and invagination is slightly delayed but otherwise no morphological defects are detectable (data not shown).
However, Fez morphants have fewer serotonergic neurons than do normal embryos and the region in which they differentiate is smaller, being restricted to an area between the bases of anterolateral arms at the 72-hour pluteus stage (Fig. 2B ). In contrast, in normal embryos, the left and right borders of the serotonergic neural complex extend up to the middle of those arms ( Fig. 2A ). This phenotype is specific because it was also obtained with a second morpholino targeted to a non-overlapping sequence in the mRNA (Fig. S1 ). There are two possibilities for the decreased number of serotonergic neurons in Fez morphants. One is that the animal plate itself becomes smaller than that of normal embryos, and another is that the size of animal plate is same but the differentiation of serotonergic neurons is perturbed at the periphery of this region. To test this, we focused on the position of the first pair of serotonergic neurons that develop near the aboral-lateral margins of the animal plate, which is marked with Nk2.1 expression (Fig. 2D, F; Yaguchi et al., 2000 : Yaguchi et al., 2006 . Although Fez morphants have fewer serotonergic neurons than do control embryos at later stages ( Fig. 2A, B ), the timing of the differentiation of the first pair of serotonergic neurons is same. In Fez morphants, these serotonergic neurons are closer to each other than those in normal embryo, and there are fewer Nk2.1-positive cells between them ( Fig. 2D ', F'). Here the serotonergic neurons are stained with anti-SynB antibody because at this stage all SynB neurons are serotonergic. In addition, the expression of homeobrain (hbn) suggests that the animal plate is smaller. hbn expression is cleared from the animal plate and surrounds it at gastrula and pluteus stages (Wei et al., 2009 ). However, the central region of clearance is smaller in Fez morphants than in controls (cf. Fig. 2G with E). Moreover, treatment of embryos with gamma-secretase inhibitor (DAPT), which suppresses Notch signaling, supports these results. In the sea urchin embryos, delta-Notch signaling suppresses differentiation of serotonergic neurons through lateral inhibition (Wei et al., 2011) . Thus, if Notch signaling is blocked, additional neural precursors can differentiate and contribute to a cluster of serotonergic neurons. If the primary function of Fez, whose early expression is in all cells of the animal plate, is to support the differentiation of each as a neuron, then the additional neurons that develop in DAPT-treated embryos (Fig. 3C) would not appear in Fez morphants. However, this is not the case, because the number of neurons increases and they form a cluster in DAPT-treated embryos, regardless of whether Fez is present or absent ( Fig. 3A-E ). This indicates that Fez is not required just for the differentiation of serotonergic neurons, but rather for determining the size of neurogenic ectoderm. Furthermore, mis-expression of Fez can significantly increase the size of the animal plate and the number of serotonergic neurons, which extend all the way to the tip of anterolateral arms (Fig. 2C, 3F , G). In addition, because the size of neural cluster along the oral-aboral axis in DAPT-treated Fez mRNA-injected embryos is wider than that in control embryos, Fez misexpression can expand the animal plate along both ciliary band and the aboral ectoderm.
Fez maintains the neurogenic ectoderm during blastula stages
The loss-of-function experiments suggest that Fez is required to maintain the size of the neurogenic animal plate in the sea urchin embryo. To investigate when Fez executes this function, we examined the expression patterns of foxQ2 and its downstream gene, nk2.1. fez begins to be expressed between hatching and mesenchyme blastula stages in control embryos (Fig. 1) , and the size of the animal plate marked by foxQ2 at both stages is almost identical in control embryos (Fig. 4A, B ). The FoxQ2-dependent gene, nk2.1, begins to be expressed at mesenchyme blastula stage in a similarly sized region of the neurogenic ectoderm ( Fig. 4C ). In contrast, in Fez morphants, the size of the foxQ2-expressing domain at mesenchyme blastula stage becomes smaller than that at hatching blastula stage ( Fig. 4D, E) , and significantly smaller than that in control embryos at the mesenchyme blastula stage (cf. Fig. 4E with B ). As well, the size of the nk2.1-expressing region decreases (Fig. 4F ). Taken together, these data indicate that Fez is required to maintain the precise size of neurogenic animal plate as soon as it is expressed between hatching and mesenchyme blastula stages. 2009; Saudemont et al., 2010; Yaguchi et al., 2010a) . To test the first alternative, we employed ∆ cadherin (∆cad) mRNA-injected embryos that lack Wnt/ß-catenin and TGF-ß signals, and develop a greatly expanded animal plate and flanking region (Logan et al., 1999; Duboc et al., 2004; Yaguchi et al., 2006; Wei et al., 2009) . In these embryos, fez is expressed throughout the expanded animal plate (Fig. S2 ). When Fez translation is blocked in ∆ cadherin (∆cad) mRNA-injected embryos with a Fez morpholino, foxQ2 expression still covers half or more of the embryo, and its distribution is not distinguishable from that of ∆ cad only-injected embryos (Fig. S2 ). This indicates that Fez does not function as an essential feedback inducer of foxQ2, an upstream regulator for animal plate development, and suggests the alternative that it functions as an inhibitor of animal plate-repressing signal(s).
BMP2/4 can restrict the neurogenic ectoderm
To test whether BMP signaling might be the postulated signal that suppresses animal plate development and that is suppressed by Fez, we examined the effects of knocking it down or mis-expressing it throughout the embryo on the expression of foxQ2 and fez. As shown in Figure 4 , loss of BMP2/4 does not expand the animal plate or significantly alter the expression of these two genes ( Fig. 4G-J) , but mis-expression strongly suppresses the expression of both (Fig. 4K , L, arrowhead and double arrowheads). We then asked whether the reduction of the animal plate in Fez morphants, as marked by foxQ2 expression, requires BMP2/4. To test this, we injected Fez and BMP2/4 morpholinos simultaneously. In Fez morphants in which BMP signaling is normal, the foxQ2 domain is reduced compared to control embryos (Fig. 4M, N) , but not in a double Fez-BMP2/4 morphant ( Fig. 4O, P) , indicating that in the absence of Fez, BMP signaling changes the size of the animal plate.
Fez protects neurogenic ectoderm against BMP signaling
Although the data strongly suggest that it is BMP2/4 signaling that reduces the animal plate in the absence of Fez, they do not rigorously rule out the possibility that, in the context of Fez-BMP2/4 double morphants, ectopic Nodal, which diffuses to the aboral side of the animal plate (Yaguchi et al., 2010a) might affect its properties or interfere with some other signal that antagonizes the animal plate. To eliminate ectopic Nodal signaling in double morphants from regions where BMP2/4 normally signals, we used an experimental embryo described previously (Yaguchi et al., 2007) , in which Nodal signaling is restricted to one side of the embryo. Endogenous Nodal is eliminated with a morpholino injection at the one-cell stage, and Nodal signaling is supplied on only one 1 side of the embryo by injecting into one blastomere at the two-cell stage mRNA encoding constitutively active Smad2/3 (actSmad2/3) along with mRNA encoding a myc marker.
This treatment forces oral and aboral fates on the injected and non-injected sides of the embryo, respectively, because actSmad2/3 activates the oral program that produces BMP2/4 ( Fig. S3 ) that diffuses to and signals to cells on the aboral side and activates the aboral ectoderm program (Yaguchi et al., 2007;  Fig. 5A-C) .
In this embryo, the number of foxQ2-positive cells in the aboral half is about 20 ( Fig. 5A-C Furthermore, all pSmad1/5/8 signals at this stage are attributable to BMP2/4 activity, because there are no signals in BMP2/4 morphants (Fig. S4 ). Before hatching blastula stage, no BMP signaling was detected, but when the embryo hatched, a clear signal appeared in the nuclei of cells in the animal half of the embryo including the animal plate marked by FoxQ2 expression (Fig. 6A, B ). However, a few hours later, at mesenchyme blastula stage, BMP2/4 signaling increased dramatically in the future aboral ectoderm and established a decreasing gradient from aboral to oral through animal plate ( Fig. 6C ; Lapraz et al., 2009 ). Based on the immunohistochemical data, the relatively strong BMP signaling area is closer to the animal pole in Fez morphants, compared with that in control embryos (Fig. 6D, E) . To further analyze this, we measured pixel values on images and used ImageJ software to quantitate relative immuno-fluorescent signal intensities that reflect the relative levels of FoxQ2 and pSmad1/5/8 proteins in nuclei in cells in a line from the animal pole to the center of the aboral side (Fig. 6F, white 
Discussion
The data presented here establish that Fez functions as soon as it is produced downstream of FoxQ2 to attenuate BMP signaling on one side of the animal plate, thereby maintaining the size of this neuroectodermal domain in the sea urchin embryo.
This mechanism is superimposed on the well-known pathway that produces a gradient of extracellular BMP activity through the activities of its antagonists or their activating proteases (Lamb et al., 1993; Sasai et al., 1994; Piccolo et al., 1997; Lee et al., 2006; Plouhinec and De Robertis, 2009 ). Fez produces a significant decline of BMP2/4 activity in the outer regions of the animal plate of the early embryo along which the serotonergic neurons will subsequently develop.
The model for the mechanism and timing of Fez function is described in Figure 7 .
Bmp2/4 begins to be expressed in prospective oral ectoderm of an unhatched blastula as a result of Nodal signaling, prior to the appearance of fez mRNA in the animal plate ( Fig.   7A ; Duboc et al., 2004; Materna et al., 2010) . Although no pSmad1/5/8 signals were observed in this embryo, it is likely that BMP2/4 protein starts to be secreted there and to signal at low levels because only a few hours later at hatching blastula stage low levels of pSmad1/5/8 can be detected in both aboral and anterior neurogenic ectoderm (Fig. 6B ).
At this time FoxQ2 and perhaps other factors induce fez transcription in animal plate cells ( Fig. 7A) . During mesenchyme blastula stages, BMP2/4 moves toward the aboral side, away from the site of bmp2/4 transcription, possibly aided by Chordin, and establishes a gradient of activity between aboral and oral sides of the embryo (Fig. 6C, 7A ; Ben-Zvi et al., 2008; Lapraz et al., 2009) . The BMP activity gradient in the neurogenic ectoderm is shallow and continuous in the absence of Fez function (Fig. 6G) , and probably reflects the normal morphogen gradient pattern in the extracellular space. However, in the normal embryo, the continuous gradient is perturbed at the border between neurogenic and non-neurogenic ectoderm by Fez (Fig. 6G, 7B, C) , sharpening the border between the animal plate and the aboral ectoderm.
The abnormal shift of the animal plate border in Fez morphants occurs on the side where BMP signals, which reduces the size of the animal plate size in these embryos.
This conclusion is supported by the observation that foxQ2 expression is reduced where BMP2/4 signaling occurs, but Nodal signaling is prevented. The consequence is that Fez functions to stabilize the border on the aboral side along which the serotonergic neurons develop, Fez is later also expressed specifically in these neurons, although it is not required to confer neuronal identity to them. Instead it may continue to protect them from BMP signaling and/or it may be involved in promoting normal axon guidance because elongation of axons in these neurons is poorly developed in Fez morphants (Fig.   2B ), as has been observed in Fez mutant mice in the olfactory bulb (Hirata et al., 2006b) .
Although the data presented here indicate that Fez is involved in attenuating BMP signaling along the outer regions of the aboral animal plate ectoderm, it is still not clear how the central part of this domain is protected against BMP2/4 signaling in Fez morphants (Fig. 6) . Although the pSmad1/5/8 activity is not as low as in normal embryos in this region of the animal plate, it may be below the threshold required to induce aboral, non-neurogenic ectoderm there. Alternatively, this central region is protected by a Fez-independent mechanism(s). The latter possibility is more likely because neurons differentiate in this region of animal pole ectoderm even when mis-expressed BMP2/4 generates dramatic down regulation of foxQ2 and fez expression in these cells at blastula stage ( Fig. 4 ; Yaguchi et al., 2006) .
Down regulation of BMP signaling along the aboral side of the animal plate by
Fez function is probably cell autonomous, although the possibility that Fez induces a short-range signal cannot be strictly ruled out. So far, because the sequence of Fez suggests that it acts as a transcriptional repressor (Hirata et al., 2006a) rather than a Smad-interacting protein, like SIP1 (Verschueren et al., 1999; van Grunsven et al., 2003; van Grunsven et al., 2007) , it is unlikely that Fez interferes directly with pSmad1/5/8 activity in intracellular region. Thus, it is possible that Fez regulates a gene(s) that is involved in pathways to maintain pSmad1/5/8 levels, such as Smad-degradation, -dephosphorylation, and/or -nucleocytoplasmic shuttling (Inman et al., 2002; Chen et al., 2006) . Target 
